In addition, ALPS patients harbouring dominant-negative Fas mutations in immune cells develop the clinical manifestations of Fas deficiency despite greater residual Fas-induced apoptosis in their T cells4. This evidence concerns the gene FAS and hyperinsulinemic hypoglycemia, familial, 4.